High altitude headache: Efficacy of acetaminophen vs. ibuprofen in a randomized, controlled trial

Journal of Emergency Medicine

Volumn 24, Issue 4, 2003, Pages 383-387

  Harris, N Stuart ^a,d   Wenzel, Richard P ^b   Thomas, Stephen H ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d NONE   (United States)

Author keywords

Acetaminophen; Headache; High altitude; Ibuprofen; Pulmonary edema

Indexed keywords

ANTIINFLAMMATORY AGENT; IBUPROFEN; PARACETAMOL;

ADOLESCENT; ADULT; ALTITUDE DISEASE; ARTICLE; BRAIN EDEMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG HYPERSENSITIVITY; FEMALE; GASTROINTESTINAL DISEASE; GASTROINTESTINAL HEMORRHAGE; HEADACHE; HUMAN; LUNG EDEMA; MALE; NAUSEA; NEPAL; OXYGEN SATURATION; PAIN ASSESSMENT; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PULSE OXIMETRY; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; VISUAL ANALOG SCALE;

EID: 0038703663     PISSN: 07364679     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0736-4679(03)00034-9     Document Type: Article

References (62)

1. Honigman B., Theis M.K., Kozoil-McLain J., et al. Acute mountain sickness in a general tourist population at moderate altitudes. Ann Intern Med. 118:1993;587-592.
2. Montgomery A.B., Mills J., Luce J.M. Incidence of acute mountain sickness at intermediate altitude. JAMA. 261:1989;732-734.
3. Johnson T.S., Rock P.B. Acute mountain sickness. N Engl J Med. 319:1988;841-845.
4. Hackett P.H., Rennie D., Levine H.D. The incidence, importance, and prophylaxis of acute mountain sickness. Lancet. 2:1976;1149-1155.
5. The Lake Louise consensus on the definition of quantification of altitude illness. Seventh International Hypoxia Symposium. Sutton J.R., Coates G., Houston C.S. Hypoxia and mountain medicine. 1991;327-330 Pergamon Press, Lake Louise, Canada.
6. Singh I., Khanna K., Srivastava M.C., Lal M., Roy S.B., Subramanya S.C.V. Acute mountain sickness. N Engl J Med. 280:1969;175-184.
7. Burtscher M., Likar R., Nachbauer W., Philadelphy M. Aspirin for prophylaxis against headache at high altitudes randomized, double blind, placebo controlled trial . BMJ. 316:1998;1057-1058.
8. Burtscher M, Likar R, Nachbauer W, Philadelphy M. Naproxen for therapy of high altitude headache. 11th International Hypoxia Symposium, Jasper 1999, abstracts.144.
9. Broome J.R., Stoneham M.D., Beeley J.M., Milledge J.S., Hughes M.B. High altitude headache treatment with ibuprofen . Aviat Space Environ Med. 65:1994;19-20.
10. Cain S.M., Dunn J.E. Low doses of acetazolamide to aid accommodation of men to altitude. J Appl Physiol. 21:1965;1195.
11. Forwand S.A., Landowne M., Follansbee J.N., Hansen J.E. Effect of acetazolamide on acute mountain sickness. N Engl J Med. 279:1968;839-845.
12. Larson E.B., Roach R.C., Schoene R.B., Hornbein T.F. Acute mountain sickness and acetazolamide clinical efficacy and effect on ventilation . JAMA. 288:1982;328-332.
13. Rock P.B., Johnson T.S., Cymerman A., Burse R.L., Falk L.J., Fulco C.S. Effect of dexamethasone on symptoms of acute mountain sickness at Pikes Peak, Colorado (4,300 m). Aviat Space Environ Med. 58:1987;668-672.
14. Levine B.D., Yoshimura K., Kobayashi I., Fukushima M., Shibamoto T., Ueda G. Dexamethasone in the treatment of acute mountain sickness. N Engl J Med. 321:1989;1707-1713.
15. Hackett P.H., Roach R.C., Wood R.A., et al. Dexamethasone for the prevention and treatment of acute mountain sickness. Aviat Space Environ Med. 59:1988;950-954.
16. Burtscher M., Likar R., Nachbauer W., Schaffert W., Philadelphy M. Ibuprofen versus sumatriptan for high-altitude headache. Lancet. 346:1995;254-255.
17. Houston C.S. Acute pulmonary edema of high altitude. N Engl J Med. 263:1960;478-480.
18. Hochstrasser J., Nanzer A., Oelz O. Das Hohen in den Schweizer Alpen. Schweiz Med Wochenschr. 116:1986;866-873.
19. Hultgren H., Spickard W., Willriegel K., et al. High altitude pulmonary edema. Medicine. 40:1961;289-313.
20. Kaminsky D.A., Jones K., Schoene R.B., Voelkel N.F. Urinary leukotriene E4 levels in high altitude pulmonary edema a possible role for inflammation . Chest. 110:1996;939-945.
21. Higgs G.A., Eakins K.E., Mugridge K.G., Moncada S., Vane J.R. The effects of non-steroidal antiinflammatory drugs on leukocyte migration in carrageenan-induced inflammation. Eur J Pharmacol. 66:1980;81-86.
22. Leman M., de Beyl V.Z., Biarent D., Maggiorini M., Melot C., Naeije R. Inhibition of cyclooxygenase and nitric oxide synthase in hypoxic vasoconstriction and oleic acid-induced injury. Am J Respir Crit Care Med. 159:1999;1383-1390.
23. Mayers I., Johnson D., Wobeser W., To T. Relative roles of prostaglandins and leukotrienes in canine hypoxic pulmonary vasoconstriction. Clin Invest Med. 14:1991;44-54.
24. Lennon P.F., Murray P.A. Attenuated hypoxic pulmonary vasoconstriction during isoflurane anesthesia is abolished by cyclooxygenase inhibition in chronically instrumented dogs. Anesthesiology. 84:1996;404-414.
25. Sprague R.S., Stephenson A.H., Longigro A.J. Prostaglandin I2 supports blood flow in hypoxic alveoli in anesthetized dogs. J Appl Physiol. 56:1984;1246-1251.
26. Ferrer M., Torres A., Baer R., Hernandez C., Roca J., Rodriguez-Roisen R. Effect of acetylsalicyclic acid on pulmonary gas exchange in patients with severe pneumonia a pilot study . Chest. 111:1997;1094-1100.
27. Maggiorini M, Melot C, Pierre S, et al. Effects of inhaled nitric oxide and inhaled prostaglandin on pulmonary hemodynamics in high altitude pulmonary edema resistant and susceptible climbers. 11th International Hypoxia Symposium, Jasper 1999, abstracts:408-9.
28. Product Information: Motrin™, ibuprofen. Pharmacia & Upjohn Company, Kalamazoo, MI; 1999.
29. AMA drug evaluations. 4th ed :1980;American Medical Association, Chicago.
30. Product Information: Tylenol™, acetaminophen. McNeil Laboratories, Fort Washington, PA; 1996.
31. Schachtel B.P., Furey S.A., Thoden W.R. Non-prescription ibuprofen and acetaminophen in treatment of tension-type headache. J Clin Pharmacol. 36:1996;1120-1125.
32. Mehlisch D.R., Sollecito W.a., Helfrick J.E., et al. Multicenter clinical trial ibuprofen and acetaminophen in treatment of post-operative dental pain. J Am Dent Assoc. 121:1990;257-263.
33. Cooper S.A., Schachtel B.P., Goldman E., Gelb S., Cohn P. Ibuprofen and acetaminophen in the relief of acute pain a randomized, double-blind, placebo-controlled study . J Clin Pharmacol. 29:1989;1026-1030.
34. Gilbert D.L. The first documented report of mountain sickness the China or Headache Mountain story . Respir Physiol. 52:1983;315-326.
35. Berre J., Vachiery J.L., Moraine J.J., Naeige R. Cerebral blood flow velocity responses to hypoxia in subjects who are susceptible to high altitude pulmonary oedema. Eur J Appl Physiol. 80:1999;260-263.
36. Reeves J.T., Moore L.G., McCullough R.E., et al. Headache at high altitude is not related to internal carotid arterial blood velocity. J Appl Physiol. 59:1985;909-915.
37. Ross R.T. The random nature of cerebral mountain sickness. Lancet. 1:1995;990-991.
38. Hackett P.H. High altitude cerebral edema and acute mountain sickness a pathophysiology update . Roach R.C., Wagner P.D., Hackett P.H. Hypoxia: into the new millennium. 1999;23-45 Kluwer Academic/Plenum Publishing, New York.
39. Burtscher M. High altitude headache epidemiology, pathophysiology, therapy, and prophylaxis . Wien Klin Wochenschr. 111:1999;830-836.
40. Strassman A.M., Raymond S.A., Burstein R. Sensitization of meningeal sensory neurons and the origin of headaches. Nature. 384:1996;560-564.
41. Hartmann G., Tschop M., Fischer R., et al. High altitude increases circulating interleukin-6, interleukin-1 receptor antagonist, and C-reactive protein. Cytokine. 12:2000;246-252.
42. Oelz O., Maggiorini M., Ritter M., et al. Pathophysiology, prevention, and therapy of high altitude pulmonary edema. Schweiz Med Wochenschrift. 122:1992;1151-1158.
43. Gibbs J.S. Pulmonary hemodynamics implications for high altitude pulmonary edema (HAPE). A review . Adv Exp Med Biol. 474:1999;81-91.
44. Bartsch P. High-altitude pulmonary edema. Respiration. 64:1997;435-443.
45. Tomlinson L.A., Carpenter T.C., Baker E.H., Bridges J.B., Weil J.V. Hypoxia reduces airway epithelium sodium transport in rats. Am J Physiol. 277:1999;L881-886.
46. Duplain H., Vollenweider L., Delabays A., Nicod P., Bartsch P., Scherrer U. Augmented sympathetic activation during short-term hypoxia and high altitude exposure in subjects susceptible to high altitude pulmonary edema. Circulation. 99:1999;1713-1718.
47. Swenson E.R., Maggiorini M., Mongovin S., et al. Pathogenesis of high altitude pulmonary edema inflammation is not an etiologic factor . JAMA. 287:2002;2228-2235.
48. Duplain H., Sartori C., Lepori M., et al. Exhaled nitric oxide in high-altitude pulmonary edema role in the regulation of pulmonary vascular tone and evidence for a role against inflammation . Am J Respir Crit Care Med. 162:2000;221-224.
49. Satori C., Allemann Y., Trueb L., et al. Exaggerated pulmonary hypertension is not sufficient trigger high-altitude pulmonary oedema in humans. Schweiz Med Wochenschr. 130:2000;385-389.
50. Hultgren H.N., Grover R.F., Hartley L.H. Abnormal circulatory responses to high altitude in subjects with a previous history of high altitude pulmonary edema. Circulation. 44:1971;759-770.
51. Fasules J.W., Wiggins J.W., Wolfe R.R. Increased lung vasoreactivity in children from Leadville, Colorado, after recovery from high altitude pulmonary edema. Circulation. 72:1985;957-962.
52. Kawashima A., Kubo K., Kobayashi T., Sekiguchi M. Hemodynamic responses to acute hypoxia, hypobaria, and exercise in subjects susceptible to high altitude pulmonary edema. J Appl Physiol. 67:1989;1982-1989.
53. Hales C.A., Rouse E.T., Slate J.L. Influence of aspirin and indomethacin on variability of alveolar hypoxic vasconstriction. J Appl Physiol. 45:1978;33-39.
54. Brimioulle S., Lejeune P., Vachiery J.L., et al. Stimulus-response curve of hypoxic pulmonary vasoconstriction in intact dogs effects of ASA . J Appl Physiol. 77:1994;476-480.
55. Leeman M., Naeije R., Lejeune P., Melot C. Influence of cyclooxygenase inhibition and of leukotriene receptor blockade on pulmonary vascular pressure/cardiac index relationships in hyperoxic and in hypoxic dogs. Clin Sci (Colch). 72:1987;717-724.
56. Gordon J.B., Moreira G.A., O'Donnell D.C., Aldinger A.M., Tod M.L. Relative effects of cyclooxygenase and nitric oxide synthase inhibition on vascular resistances in neonatal lamb lungs. Pediatr Res. 42:1997;738-743.
57. Marshall C., Kim S.D., Marshall B.E. The actions of halothane, ibuprofen, and BW755C on hypoxic pulmonary vasoconstriction. Anesthesiology. 66:1987;537-542.
58. Weir E.K., McMurty I.F., Tucker A., Reeves J.T., Grover R.F. Prostaglandin synthetase inhibitors do not decrease hypoxic pulmonary vasoconstriction. J Appl Physiol. 41:1976;714-718.
59. Berkowitz B.A., Sabko-Potapovich B., Valocik R., Gleason J.G. Effects of the leukotrienes on the vasculature and blood pressure of different species. J Pharmocol Exp Ther. 229:1984;105-112.
60. Morganroth M.L., Reeves J.T., Murphy R.C., Voelkel N.F. Leukotriene synthesis and receptor blockers block hypoxic pulmonary vasoconstriction. J Appl Physiol. 56:1984;1340-1346.
61. Fan M., Zhu Z.H., Wang D.X. Effect of endotoxin on hypoxic pulmonary vasoconstriction - the role of prostaglandins and leukotrienes. J Tongji Med Univ. 12:1992;11-16.
62. Doughty H.A., Beardmore C. Bleeding time at altitude. J R Soc Med. 87:1994;317-319.